skip to main content

Klebsiella pneumoniae subsp. pneumoniae

Klebsiella pneumoniae subsp. pneumoniae

Catalogue No.

NCTC 13625

Current Name

Klebsiella pneumoniae subsp. pneumoniae

Type Strain

Reference Strain

Original Strain Reference

bMx# 1103199

Culture Conditions

Growth Conditions on Solid Media

Nutrient agar, 24 hours, 37°C, O₂

Biological and Genomic Info

Antimicrobial Susceptibility

MIC Etest:

Imipenem = 0.38µg/ml

Meropenem = 0.25µg/ml

Ertapenem = 0.75µg/ml

Antimicrobial Resistance Mechanism

Carbapenemase producer, OXA-48

Gram Stain Result

Negative

Additional Info

Accession Date

04/12/2012

Depositor

Regine Cuziat bioMérieux S.A.

Isolated From

Human, Turkey

History

NCTC <-Depositor <-. Pr Nordmann Hospital Bicetre, Kremlin Bicetre, France <.Originator

Applications

Applications

QC strain for "chromID Oxa48"

Available Formats

  • Ampoule (Bacteria)

If use of this culture results in a scientific publication, it should be cited in the publication as: Klebsiella pneumoniae subsp. pneumoniae (NCTC 13625)

It is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.